CRISPR ended 2023 with a bang.In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in...

A tiny ball of brain cells hums with activity as it sits atop an array of electrodes. For two days, it receives a pattern...

SC-2882 shows anti-lymphoma and anti-immunosuppression effect in a mouse model for diffuse large B-Cell lymphoma Data presented today, December 9, at the 65th ASH Annual...

VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #AI–ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), today announced the closing of its $1.265 million underwritten...

Jamie King, one of the original founders of Grand Theft Auto maker Rockstar Games, has joined the Cayman Islands-based Portal Foundation as an advisor...

Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer. The collaboration...

Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies. The German company announced earlier this...

Company Announces Core Leadership Team, Led by CEO, Kerry L. Blanchard, MD, PhD SHANGHAI & BOSTON–(BUSINESS WIRE)–Perpetual Medicines today announced it has closed an $8...

Exclusive arrangement will expand market access to Personalis’ ultra-sensitive MRD test FREMONT, Calif. & CHICAGO–(BUSINESS WIRE)–Personalis, Inc., a leader in advanced genomics for precision oncology...

X-ray detectors play a key role in a wide range of medical applications, including diagnostic imaging, radiotherapy dosimetry and personal radiation...

CRISPR-based therapies just hit another milestone.In a small clinical trial with 10 people genetically prone to dangerously high levels of cholesterol, a single infusion...

– Zilebesiran Met Primary Endpoint Demonstrating Up to 16.7 mmHg Placebo-Adjusted Reduction of 24-Hour Mean Systolic Blood Pressure at Three Months of Treatment – –...